| Honoré, Jan (BankInvest 200502) |
Board member, non-executive |
BankInvest (Group) |
Denmark |
| Horak, Ivan (Symphogen 201405 CSO + CMO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Servier (Group) |
Denmark |
| Hornstein, Jörg (Lundbeck 202209– CFO before AC Immune + Theo Müller Group + Merck KGaA) |
Chief Financial Officer (CFO) |
Lundbeck (Group) |
Denmark |
| Hotchkiss, Andrew (Draupnir Bio 202106– CEO before Dermira + Immunocore + Lilly) |
Chief Executive Officer (CEO) |
Draupnir Bio ApS |
Denmark |
| Hyttel, John (Zealand Pharma 1998–200301 COO + Co-founder RETIRED 1/13) |
Chief Operating Officer (COO) |
Zealand Pharma (Group) |
Denmark |
| Håkansson, Hans-Bertil (Zacco 200804 CEO) |
Chief Executive Officer (CEO) |
Zacco (Group) |
Denmark |
| Högberg, Thomas (Mind the Byte 201711 Chief Strategic Officer) |
Business Development Manager / Strategy Manager |
Mind the Byte (Group) |
Denmark |
| Jakobsen, Søren N. (Tetramer Shop 202102 Co-Founder) |
Company Founder |
10x Genomics (Group) |
Denmark |
| Jelsing, Jacob (Gubra 202205– Board Chair + Co-Founder before CSO) |
Board member, non-executive |
Gubra ApS |
Denmark |
| Jenne, Andreas (RSP Systems 201805– CEO before NEO New Oncology + Blackfield + Kinaxo) |
Chief Executive Officer (CEO) |
RSP Systems A/S |
Denmark |
| Jensen, Johannes (Novo Group 200501 VP of Novo Nordisk Biotech Fund) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Joecker, Anika (CLC bio 201109 Bioinformatics Specialist) |
n. a. |
Qiagen (Group) |
Denmark |
| Johansen, Erling (Bavarian Nordic 200804 Managing Director) |
Managing Director |
Bavarian Nordic (Group) |
Denmark |
| Jorgensen, Rasmus (Cytoki Pharma 202105 CEO + Founder) |
Chief Executive Officer (CEO) |
Cytoki Pharma ApS |
Denmark |
| Juhl, Søren Danielsen (Denmark (govt) 202310 at EIFO) |
n. a. |
Denmark (govt) |
Denmark |
| Juuel, Henrik (Bavarian Nordic 201811– before Orexo + Virgin Mobile + GN ReSound + NNE Pharmaplan + Novo Nordisk) |
Chief Financial Officer (CFO) |
Bavarian Nordic (Group) |
Denmark |
| Jørgensen, John Bagterp (Technical Univ of Denmark 202107 Professor at Dept of Applied Mathematics + Computer Science) |
Professor |
Technical University of Denmark (DTU) |
Denmark |
| Jørgensen, Lars Fruergaard (Novo Group 201701– CEO of Novo Nordisk before EVP Corp Development joined 1991) |
Chief Executive Officer (CEO) |
Novo Group (Group) |
Denmark |
| Kabel, Thomas (21st.BIO 202112 CFO before Novozymes) |
Chief Financial Officer (CFO) |
21st.BIO A/S |
Denmark |
| Kainu, Tommi (Bavarian Nordic 201707– CBO before Boston Consulting + NIH) |
Chief Business Officer (CBO) |
Bavarian Nordic (Group) |
Denmark |
| Kakar, Amit (Novo Group 202203 Senior Partner + Head of Novo Holdings Equity Asia) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Karas, Holger (CLC bio 201104– before Nihon Biobase KK 200801– CEO + co-founder + BusDev Biobase) |
Consultant (economic/technology) |
Qiagen (Group) |
Denmark |
| Karsdal, Morten Asser (Nordic Bioscience 201706 Board Chairman of KeyBioscience AG) |
Board member |
CCBR (Group) |
Denmark |
| Kaufhold, Achim (Basilea 201211 CMO before Affitech A/S + Pharmexa + Chiron + Berna Biotech + GSK) |
Chief Medical Officer (CMO) |
Pharmexa (Group) |
Denmark |
| Keith Mc Cullagh (Santaris 200607 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Denmark |
| Kilburn, Paul (Lundbeck 201903 Director + Head of Medicinal Chemistry) |
Research & Development Manager |
Lundbeck (Group) |
Denmark |
| Kjeldal, Klaus (DakoCytomation 200506 Corporate VP Operations) |
Chief Operating Officer (COO) |
Agilent (Group) |
Denmark |
| Kjøller, Kim (Leo Pharma 201201 SVP Global Development) |
Research & Development Manager |
Leo Pharma (Group) |
Denmark |
| Kledal, Thomas (Synklino 202110 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Synklino ApS |
Denmark |
| Knudsen, Thomas (CLC bio 200701 CEO) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
Denmark |
| Koch, Jörn |
n. a. |
University of Aarhus (DK) |
Denmark |
| Kofoed, Thomas (Alphalyse 201706 CEO) |
Chief Executive Officer (CEO) |
Zymenex (Group) |
Denmark |
| Kollerup, Simon (Denmark (govt) 202007 Minister for Industry, Business + Financial Affairs) |
Minister |
Denmark (govt) |
Denmark |
| Kongsbak, Lars (Samplix 201901 CEO before Exiqon 2003–2017 CEO) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
Denmark |
| Kring, Ole (Scandinavian Micro Biodevices 200603 CEO) |
Chief Executive Officer (CEO) |
Zoetis (Group) |
Denmark |
| Kristensen, Klaus (Pipeline Biotech 201201– CBO + Owner + Founder before CEO) |
Chief Business Officer (CBO) |
Pipeline Biotech A/S |
Denmark |
| Krogh Hansen, Johnny (Pipeline Biotech 201201– CEO / Managing Director before Genzyme A/S Country Manager) |
Chief Executive Officer (CEO) |
Pipeline Biotech A/S |
Denmark |
| Krogh, Peter (Ellab 201908 CEO) |
Chief Executive Officer (CEO) |
Novo Group (Group) |
Denmark |
| Krogsgaard Thomsen, Mads (Novo Nordisk 200702 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Novo Group (Group) |
Denmark |
| Krogsgaard, Randi (Biopeople 201811 Cluster Manager) |
Cluster Manager |
Biopeople (Denmark’s Life Science Cluster) |
Denmark |
| Kronborg, Anders (Leo Pharma 201510– EVP Global Finance, IT + Legal before Kinnevik Investment AB) |
Chief Financial Officer (CFO) |
Leo Pharma (Group) |
Denmark |
| Kronborg, Mads (Lundbeck 201309 Media Relations Manager) |
Public Relations Manager / Investor Relations Manager |
Lundbeck (Group) |
Denmark |
| Kruse, Bo (Genmab 2000–200508ex) |
n. a. |
Genmab (Group) |
Denmark |
| Kutay, Kasim (Novo Group 201706 CEO of Novo Holdings A/S) |
Chief Executive Officer (CEO) |
Novo Group (Group) |
Denmark |
| Ladegaard, Torben (FOSS 201302 CEO) |
Chief Executive Officer (CEO) |
FOSS (Group) |
Denmark |
| Lademann, Anne-Marie (Egalet 200109 BusDev Manager) |
Business Development Manager / Strategy Manager |
Egalet (Group) |
Denmark |
| Langa, Doug (Novo Group 201703– promoted Head North America + President Novo Nordisk Inc joined Novo Nordisk in 2011) |
Regional manager |
Novo Group (Group) |
Denmark |
| Lange, Jesper J. (MC2 Therapeutics 202102 CEO) |
Chief Executive Officer (CEO) |
MC2 Therapeutics A/S |
Denmark |
| Langhärig, Jürgen (Evaxion Biotech 201910– Head of Business Development before Serodus) |
Business Development Manager / Strategy Manager |
Evaxion Biotech A/S (Nasdaq: EVAX) |
Denmark |
| Laquian, Ian (Novo Group 201911 at BiOrigin before Nycomed + Takeda) |
n. a. |
Novo Group (Group) |
Denmark |
| Larsen, Ole (Bavarian Nordic 2008–2018 LEFT in 2018 as CFO) |
Chief Financial Officer (CFO) |
Bavarian Nordic (Group) |
Denmark |
| Larson, Thomas A. (Ascendis Pharma 201804– CCO before Mitsubisi Tanabe Pharma America + Marathon Pharmaceuticals) |
Chief Commercial Officer (CCO) |
Ascendis Pharma (Group) |
Denmark |
| Lassen, David Dreyer (Univ Copenhagen 202310 at UCPH Ventures) |
Investment Manager |
UCPH Ventures (University of Copenhagen) |
Denmark |
| Laursen, Torben Jung (Action Pharma 200902– VP BusDev before Alpharma + Roche + Novo Nordisk) |
Business Development Manager / Strategy Manager |
Action Pharma A/S |
Denmark |
| Laustsen, Mads (CMC Biologics 200808 CEO) |
Chief Executive Officer (CEO) |
Asahi Glass (AGC) (Group) |
Denmark |
| Lele, Abhijeet (Novo Group 202102 Senior Partner Head of Principal Investments in US at Novo Holdings) |
Partner (venture partner) |
Novo Group (Group) |
Denmark |
| Lemonius, Søren (Sunstone Capital 201905 Founding Partner) |
Managing Partner (investment firm) |
Sunstone Life Science (Group) |
Denmark |
| Lercke, Camilla (Chr Hansen 201904 Head of Media Relations) |
Public Relations Manager / Investor Relations Manager |
Chr. Hansen (Group) |
Denmark |
| Leth Hillman, Hanne (Zealand Pharma 201508 SVP Investor Relations + Communications) |
Public Relations Manager / Investor Relations Manager |
Zealand Pharma (Group) |
Denmark |
| Li, Ning (BGI 201202 Director of BGI Europe) |
President/Director/Head Business Group/Unit/Division |
BGI (CN) (Group) |
Denmark |
| Linde, Svend Aage (Eurofins 200701 Managing Director Eurofins Denmark [Mikjö-Kemi]) |
Managing Director |
Eurofins (Group) |
Denmark |
| Lindhardt, Karsten (Biograil 202001 CEO before Egalet + Novo Nordisk + Ferring + Prosidion + Curalogic) |
n. a. |
Biograil ApS |
Denmark |
| Lindsay, John (Proxeon 200711– VP Sales and Marketing North America) |
Sales Manager / Marketing Manager |
Thermo Fisher (Group) |
Denmark |
| Ljungmann, Torstein (Dako 200809– before InstrumeC) |
n. a. |
Agilent (Group) |
Denmark |
| Ljungmann, Øystein (Dako 200809– before InstrumeC) |
n. a. |
Agilent (Group) |
Denmark |
| Lomholdt, Jan (CLC bio 200804 Vice President) |
n. a. |
Qiagen (Group) |
Denmark |
| Lunding, Ernst (LEO Pharma 200611 CEO) |
Chief Executive Officer (CEO) |
Leo Pharma (Group) |
Denmark |
| Luthman, Johan (Lundbeck 202008 EVP RnD) |
Research & Development Manager |
Lundbeck (Group) |
Denmark |
| Madsen, Torsten M. (Hoba Therapeutics 202210 CEO) |
Chief Executive Officer (CEO) |
Hoba Therapeutics (DK) |
Denmark |
| Mahler, Gustavo (CMC Biologics 201412 Global COO) |
Chief Operating Officer (COO) |
Asahi Glass (AGC) (Group) |
Denmark |
| Mahony, Daniel (Dan) (Novo Group 202401– Senior Partner Novo Growth Investments + BIA before Trellus + Evotec) |
n. a. |
Novo Group (Group) |
Denmark |
| May, Jean-Christophe (Bavarian Nordic 202001– CCO before GSK Vaccines) |
Chief Commercial Officer (CCO) |
Bavarian Nordic (Group) |
Denmark |
| Mazzacco, Catherine (Leo Pharma 201908– CEO before GE Healthcare biopharma division + Abbott) |
Chief Executive Officer (CEO) |
Leo Pharma (Group) |
Denmark |
| McCullagh, Keith (Santaris Pharma 200506 CEO) |
Chief Executive Officer (CEO) |
Roche (Group) |
Denmark |
| Median, Juan P. (Kaffe Bueno 202010 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Kaffe Bueno ApS |
Denmark |
| Meelby Jensen, Britt (Zealand Pharma 201508 CEO) |
Chief Executive Officer (CEO) |
Zealand Pharma (Group) |
Denmark |
| Meyer, Henrik (Cysbio 201903 CEO) |
Chief Executive Officer (CEO) |
Cysbio ApS |
Denmark |
| Mikkelsen, Jan (Ascendis Pharma 201609 CEO) |
Chief Executive Officer (CEO) |
Ascendis Pharma (Group) |
Denmark |
| Mogensen, Søren Skjold (SSI Diagnostica 202208 CEO) |
Chief Executive Officer (CEO) |
SSI Diagnostica (SSID) (Group) |
Denmark |
| Moresco, Jacob L. (Sunstone Life Science Ventures 202103) |
Investment Manager |
Sunstone Life Science (Group) |
Denmark |
| Morgan, Diana (CMC Biopharmaceuticals 200712 CBO) |
Chief Business Officer (CBO) |
Asahi Glass (AGC) (Group) |
Denmark |
| Mortensen, Thomas Mikkel (Lundbeck 202204 Media Relations) |
Public Relations Manager / Investor Relations Manager |
Lundbeck (Group) |
Denmark |
| Mostrup Scheel, Christian (Novo Group 201706 Senior Press OFficer of Novo Holdings A/S) |
Public Relations Manager / Investor Relations Manager |
Novo Group (Group) |
Denmark |
| Mouritzen, Ulrik (Breye Therapeutics 202307 CEO) |
Chief Executive Officer (CEO) |
Breye Therapeutics ApS |
Denmark |
| Munck, Christian (Enduro Genetics 202012 Co-Founder) |
n. a. |
Enduro Genetics ApS |
Denmark |
| Munis Zepernick, David (Medicon Valley Alliance 202001 Head of Communication + Public Affairs) |
Public Relations Manager / Investor Relations Manager |
Medicon Valley Alliance (MVA) |
Denmark |
| Mølgaard, Simon (Teitur Trophics 202303 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Teitur Trophics ApS |
Denmark |
| Møller, Claus (Azanta 201206 CEO) |
Chief Executive Officer (CEO) |
Azanta (Group) |
Denmark |
| Møller, Jesper Sloth (Lundbeck 202204 Head of Media Relations at Lundbeckfonden) |
Public Relations Manager / Investor Relations Manager |
Lundbeck (Group) |
Denmark |
| Møller, Niels Eversen (Evaxion Biotech 202102 CBO before CEO + Co-founder before Medical Prognosis + AstraZeneca) |
Chief Business Officer (CBO) |
Evaxion Biotech A/S (Nasdaq: EVAX) |
Denmark |
| Møller, Søren (Novo Group 201505 Managing Investment Director at Novo Seeds) |
Investment Manager |
Novo Group (Group) |
Denmark |
| Mørk, Alejandra (KLIFO 2008– Owner + CEO) |
Chief Executive Officer (CEO) |
KLIFO (Group) |
Denmark |
| Nagy, Thomas (21st.BIO 202112 COO before Novozymes) |
Chief Operating Officer (COO) |
21st.BIO A/S |
Denmark |
| Nauntofte, Birgitte (Novo Group 202012 CEO of Novo Nordisk Foundation) |
n. a. |
Novo Group (Group) |
Denmark |
| Naval, Jordi (InProTher 202102–Biocat 202003 CEO) |
Chief Executive Officer (CEO) |
InProTher ApS |
Denmark |
| Nellemann Pedersen, Michael (PKA 202206 Chief Investment Officer) |
Investment Manager |
PKA Pension Fund (DK) |
Denmark |
| Nielsen, Jens (BioInnovation Institute 202012– CEO) |
Chief Executive Officer (CEO) |
BioInnovation Institute (BII Foundation) |
Denmark |
| Nielsen, Nicolaj (Inprother ApS 201912 CFO) |
Chief Financial Officer (CFO) |
InProTher ApS |
Denmark |
| Nielsen, Peder Holk (Novo Group 201407 CEO of Novozymes) |
Chief Executive Officer (CEO) |
Novozymes (Group) |
Denmark |
| Nielsen, Søren (Action Pharma 200902 CEO) |
Chief Executive Officer (CEO) |
CPTone Biotech ApS |
Denmark |
![[LSE] Life-Sciences-Europe.com - The European Life Sciences Web Portal](/images/basics/lse-life-sciences-europe-portal-logo.svg){kind=logo}
1 2 3 4 ... 40 41 42 
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
